INTELLIGENCE IN ACTION

HIMSS17: Combating the Opioid Epidemic

February 08, 2017

Our nation has been crippled by the devastating opioid addiction epidemic. According to the Centers for Disease Control, opioid drug overdoses played a role in 33,091 deaths in the United States in 2015, and that number is expected to continue to rise.

To address this growing public health crisis, healthcare industry experts must work together to develop innovative and effective solutions. Electronic prescribing of controlled substances (EPCS) is one weapon providers can use to help curb fraud and abuse. Digitizing the prescribing process makes it easier for patients to get the chronic pain treatments they need, while making it harder for people to divert and illegally distribute prescription drugs. Providers are beginning to realize the power of EPCS, as evident in Surescripts’ 2015 National Progress Report. According to the report, EPCS increased by 667 percent in 2015 and the number of providers with EPCS technology increased by 359 percent.

Surescripts will host a panel discussion at HIMSS17 to explore how actionable intelligence, including access to medication history data, can help address the opioid crisis. The “Combating the Opioid Epidemic” panel will take place on Monday, February 20 at 3:45 p.m. EST at Surescripts booth #6660. I am excited to be the moderator of the panel and look forward to exploring how information access, data sharing and new technology can help address fraud and abuse. The panel will feature perspectives from care providers and technology developers who are taking action, including:

For more information on HIMSS17 and our presence at the event, visit himssconference.org and check out the Surescripts blog. Be sure to follow the conversation on Twitter via the @Surescripts handle and #HIMSS17 hashtag.

Combatting the Opioid Epidemic

Related Articles

September 15, 2020

The Opioid Crisis Is Still with Us

Mental health experts and the recovery community have been sounding the alarm for months now. But there are things that the healthcare industry is doing—and can continue to embrace—that are of real help in combatting the crisis. 

Read more...
July 16, 2020

Revisiting a Groundbreaking Prescribing Regulation

More than a decade ago, the U.S. Drug Enforcement Administration (DEA) published its Electronic Prescribing for Controlled Substances (EPCS) Interim Final Rule (IFR). Surescripts applauded this regulation, which took effect on June 1, 2010. 

Read more...
March 31, 2020

Five Questions: Ken Whittemore Talks Past, Present & Future of E-Prescribing Controlled Substances

In the early 2000s, as the nation moved towards e-prescribing, Ken Whittemore Jr. was one of the key drivers and proponents of this new technology. By 2007, as a result of the efforts of Surescripts and other stakeholders, e-prescribing had become legal in all 50 states. Three years later, the regulatory climate was ready for the next leap in e-prescribing: in March 2010, the U.S. Drug Enforcement Administration (DEA) issued an Interim Final Rule (IFR) allowing for the electronic prescribing of controlled substances (EPCS) across the nation.  Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX